Yahoo Web Search

Search results

1. • 

     Brainstorm Cell Therapeutics Inc.'s (NASDAQ:BCLI) Path To Profitability

     Simply Wall St. via Yahoo Finance· 7 months ago

     Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) is possibly approaching a major achievement in its...

2. • 

     While institutions own 23% of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), retail investors are...

     Simply Wall St. via Yahoo Finance· 11 months ago

     Key Insights Brainstorm Cell Therapeutics' significant retail investors ownership suggests that the...

3. • 

     Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2022 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 1 year ago

     Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2022 Earnings Call Transcript March 30, 2023...

4. • 

     FDA Refuses To Accept BrainStorm Cell's Lead Candidate For Amyotrophic Lateral Sclerosis

     Benzinga via Yahoo Finance· 1 year ago

     BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) received a refusal to file letter from the FDA...

5. • Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 8 months ago

     Participants Chaim Lebovits; President & CEO; Brainstorm Cell Therapeutics Inc. Stacy Lindborg; Co-CEO; Brainstorm Cell Therapeutics Inc. Alla Patlis; Interim CFO; Brainstorm Cell Therapeutics ...

6. • 

     Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More

     Zacks via Yahoo Finance· 1 year ago

     Drug approvals and other regulatory news are in focus in the biotech sector. Updates on booster...